DCTH

Delcath Systems (DCTH)

About Delcath Systems (DCTH)

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Details

Daily high

$10.20

Daily low

$9.84

Price at open

52 Week High

$18.23

52 Week Low

$8.12

Market cap

354.2M

Dividend yield

0.00%

Volume

256

Avg. volume

753,997

P/E ratio

1,166.28

Delcath Systems News